The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
Open accessAbstract
Background: Clinicians use fibrosis in a liver biopsy to predict clinical outcomes of chronic liver disease. The performance of non-invasive tests has been evaluated against histological assessment of fibrosis but use of clinical outcomes as the reference standard would be ideal. The enhanced liver fibrosis (ELF) test was derived and validated in a large cohort of patients and shown to have high diagnostic accuracy (area under the curve (AUC)=0.80 95% CI 0.76 to 0.85) in identification of significant fibrosis on biopsy. Objective: To evaluate ELF performance in predicting clinical outcomes by following up the original ELF cohort. Methods: Patients recruited to the ELF study at seven English centres were followed up for liver morbidity and mortality by examination of clinical data. Defaulting/discharged patients were followed up by family practitioner questionnaires. Primary outcome measure was liver-related morbidity/liver-related death. Results: 457 patients were followed up (median 7 years), with ascertainment of clinical status in 92%. There were 61 liver-related outcomes (39 deaths). Survival analysis showed that the ELF score predicts liver outcomes, with people having the highest ELF scores being significantly more likely to have clinical outcomes than those in lower-score groups. A Cox proportional hazards model showed fully adjusted HRs of 75 (ELF score 12.52–16.67), 20 (10.426–12.51) and 5 (8.34–10.425) compared with patients with ELF <8.34. A unit change in ELF is associated with a doubling of risk of liver-related outcome. Conclusions: An ELF test can predict clinical outcomes in patients with chronic liver disease and may be a useful prognostic tool in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
Bedossa, P., Dargère, D., & Paradis, V. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.022 · Cited by 2,376
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Serum markers detect the presence of liver fibrosis: A cohort study
Rosenberg, W. M. C., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D., Hubscher, S., Roskams, T., Pinzani, M., & Arthur, M. J. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.052 · Cited by 1,102
Self-citationGuha, I. N., Parkes, J., Roderick, P., Chattopadhyay, D., Cross, R., Harris, S., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., et al. (2008) · Hepatology · doi:10.1002/hep.21984 · Cited by 745
Self-citationSources of variability in histological scoring of chronic viral hepatitis†
Rousselet, M., Michalak, S., Dupré, F., Croué, A., Bedossa, P., Saint‐André, J., & Calès, P. (2005) · Hepatology · doi:10.1002/hep.20535 · Cited by 540
A comparison of fibrosis progression in chronic liver diseases
Poynard, T., Mathurin, P., Lai, C.-L., Guyader, D., Poupon, R., Tainturier, M.-H., Myers, R. P., Muntenau, M., Ratziu, V., Manns, M., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00413-0 · Cited by 474
Spectrum Bias or Spectrum Effect? Subgroup Variation in Diagnostic Test Evaluation
Mulherin, S. A., & Miller, W. C. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00011 · Cited by 327
Naveau, S., Gaudé, G., Asnacios, A., Agostini, H., Abella, A., Barri‐Ova, N., Dauvois, B., Prévot, S., Ngo, Y., Munteanu, M., et al. (2009) · Hepatology · doi:10.1002/hep.22576 · Cited by 293
Nobili, V., Parkes, J., Bottazzo, G., Marcellini, M., Cross, R., Newman, D., Vizzutti, F., Pinzani, M., & Rosenberg, W. M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.013 · Cited by 265
Self-citationNgo, Y., Munteanu, M., Messous, D., Charlotte, F., Imbert-Bismut, F., Thabut, D., Lebray, P., Thibault, V., Benhamou, Y., Moussalli, J., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.070961 · Cited by 229
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay
Mayo, M. J., Parkes, J., Adams-Huet, B., Combes, B., Mills, A. S., Markin, R. S., Rubin, R., Wheeler, D., Contos, M., West, A. B., et al. (2008) · Hepatology · doi:10.1002/hep.22517 · Cited by 198 · cited 1×
“which has been shown to be accurate in predicting significant liver fibrosis in independent populations.”
BackgroundSelf-citationSurveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis
Thompson Coon, J., Rogers, G., Hewson, P., Wright, D., Anderson, R., Cramp, M., Jackson, S., Ryder, S., Price, A., & Stein, K. (2007) · Health Technology Assessment · doi:10.3310/hta11340 · Cited by 195
Parkes, J., Guha, I. N., Roderick, P., Harris, S., Cross, R., Manos, M. M., Irving, W., Zaitoun, A., Wheatley, M., Ryder, S., et al. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01263.x · Cited by 180
Self-citationTaxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation
Ward, S., Simpson, E., Davis, S., Hind, D., Rees, A., & Wilkinson, A. (2007) · Health Technology Assessment · doi:10.3310/hta11400 · Cited by 179
Christensen, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.005 · Cited by 147
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
Halfon, P., Munteanu, M., & Poynard, T. (2008) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(08)73991-5 · Cited by 125
Yu, M., Lin, S., Lee, C., Dai, C., Chang, W., Chen, S., Lee, L., Lin, Z., Hsieh, M., Wang, L., et al. (2006) · Hepatology · doi:10.1002/hep.21363 · Cited by 113
Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis
Guechot, J., Serfaty, L., Bonnand, A.-M., Chazouillères, O., Poupon, R. E., & Poupon, R. Y. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80396-7 · Cited by 100
Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value
Körner, T. W., Kropf, J., & Gressner, A. M. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80239-x · Cited by 100
Goehring, C., Perrier, A., & Morabia, A. (2003) · Statistics in Medicine · doi:10.1002/sim.1591 · Cited by 90
Ngo, Y., Benhamou, Y., Thibault, V., Ingiliz, P., Munteanu, M., Lebray, P., Thabut, D., Morra, R., Messous, D., Charlotte, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002573 · Cited by 80
The burden of hepatitis C in England
Sweeting, M. J., Angelis, D. D., Brant, L. J., Harris, H., Mann, A. G., & Ramsay, M. E. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00851.x · Cited by 67
Liver cirrhosis mortality rates in Britain, 1950 to 2002
Leon, D. A., & McCambridge, J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68250-0 · Cited by 48
Rating fibrosis progression in chronic liver diseases
Rosenberg, W. M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00010-2 · Cited by 42
Self-citation
Cited by
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.006 · Cited by 1,875
“FibroTest® [21] Forns Index [22] APRI [23] FibroSpectII® [24] MP3 [25] FPI [26] Hepascore® [27] Lok index [28] GUCI [29] ViraHep-C [30] Fibroindex [31] FIB-4 [32] HALT-C model [33] Hui Score [36] Zeng score [37] SHASTA [38] FIB-4 [39] ELF® [34] Fibrometer® [35] NFS [40] BARD score [41] HCV HCV HCV HCV HCV HCV HCV HCV…”
BackgroundInfluentialTsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60121-5 · Cited by 1,740
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,088
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Metadata
- Authors
- Parkes, J., Roderick, P., Harris, S., Day, C., Mutimer, D., Collier, J., Lombard, M., Alexander, G., Ramage, J., Dusheiko, G., Wheatley, M., Gough, C., Burt, A., & Rosenberg, W.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2010-07-30
- Volume
- 59
- Issue
- 9
- Pages
- 1245-1251
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2121514783
- Cited by
- 351
- References
- 29
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.